From target gene to lead compound
leadXpro specializes in structure-based drug discovery for membrane proteins.
Achievements as of December 2022:
- Total number of targets solved: 25, (23 ion channels, 22 GPCRs, 13 transporters, 3 enzymes).
- Novel targets enabled: 7
- Total number of proteins: 61
We have an integrated platform for membrane protein biochemistry, biophysics and structural biology, including X-ray crystallography and cryo-EM.